Log in to save activitiesYour saved activities will show here so that you can easily access them whenever you're ready. Log in hereCME & EducationLog in to keep track of your credits.
Please confirm that you would like to log out of Medscape.
If you log out, you will be required to enter your username and password the next time you visit.
Log outCancel
COMPASS For patients with stable atherosclerotic vascular
disease, rivaroxaban 2.5 mg twice daily plus aspirin had better CV outcomes than aspirin alone.
XANTUS How are NOACs being used in the real world? Studies such as XANTUS provide an insight.
RE-DUAL PCIFor AF patients undergoing PCI, bleeding risk was lower in those receiving dabigatran and a P2Y12 inhibitor vs triple therapy.
EMANATEApixaban lowers the risk of stroke vs warfarin in patients with AF scheduled for elective cardioversion.
IMPACT-AFThis multifaceted and multilevel educational intervention improved use of oral anticoagulation in patients with AF and at risk for stroke.
REHEARSE-AF Twice-weekly screening with an iECG in patients ≥65 years at risk of stroke is significantly more likely to identify incident AF than routine care.
